Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics

[1]  F. Sera,et al.  Founder mutations account for the majority of BRCA1-attributable hereditary breast/ovarian cancer cases in a population from Tuscany, Central Italy , 2009, Breast Cancer Research and Treatment.

[2]  P. Radice,et al.  Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families. , 2007, European journal of cancer.

[3]  A. Musolino,et al.  A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes , 2005, Breast Cancer Research and Treatment.

[4]  R. Eeles,et al.  Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations , 2005, Journal of Medical Genetics.

[5]  D. Carter,et al.  Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ. , 2005, JAMA.

[6]  B. Haffty,et al.  Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Godino,et al.  A breast cancer family from Spain with germline mutations in both the BRCA1 and BRCA2 genes , 2002, Journal of medical genetics.

[8]  D. Sgroi,et al.  Selective loss of heterozygosity in multiple breast cancers from a carrier of mutations in both BRCA1 and BRCA2. , 2002, Cancer research.

[9]  Sean V Tavtigian,et al.  Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  E. Steegers,et al.  Paternal contribution to the risk for pre-eclampsia , 2002, Journal of medical genetics.

[11]  P. Radice,et al.  Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer , 2001, Human mutation.

[12]  K. Phillips.  Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  S. Narod,et al.  An unaffected individual from a breast/ovarian cancer family with germline mutations in both BRCA1 and BRCA2 , 2000, Clinical genetics.

[14]  G. Giles,et al.  De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation. , 1999, American journal of human genetics.

[15]  S. Seal,et al.  Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. , 1999, Journal of the National Cancer Institute.

[16]  S Wacholder,et al.  The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. , 1999, American journal of human genetics.

[17]  R. Gershoni-baruch,et al.  Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes. , 1998, American journal of human genetics.

[18]  J. Boyd,et al.  Germline mutations of the BRCA1 and BRCA2 genes in a breast and ovarian cancer patient. , 1998, Gynecologic oncology.

[19]  H. Yokozaki,et al.  [Hereditary non-polyposis colorectal cancer]. , 1998, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

[20]  S. Narod,et al.  A breast cancer patient of Scottish descent with germ-line mutations in BRCA1 and BRCA2. , 1998, American journal of human genetics.

[21]  R. Gershoni-baruch,et al.  Co-segregation of BRCA1 185delAG mutation and BRCA2 6174delT in one single family. , 1997, European journal of cancer.

[22]  M. Skolnick,et al.  BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations. , 1996, Oncogene.

[23]  Kenneth Offit,et al.  The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1% , 1996, Nature Genetics.

[24]  Alfred A. Boyd,et al.  Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2 , 1996, Nature Genetics.

[25]  F. Collins,et al.  The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals , 1995, Nature Genetics.

[26]  I. Winship,et al.  Familial breast cancer: double heterozygosity for BRCA1 and BRCA2 mutations with differing phenotypes , 2007, Familial Cancer.

[27]  S. Loader,et al.  Deleterious mutations of both BRCA1 and BRCA2 in three siblings. , 1998, Genetic testing.

[28]  B. Ponder,et al.  A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2 , 1997, Nature Genetics.